Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, S.W. | - |
dc.contributor.author | Lee, W.C. | - |
dc.contributor.author | Kim, M.T. | - |
dc.contributor.author | Ko, K. | - |
dc.contributor.author | Lee, W.K. | - |
dc.contributor.author | Lee, C.-H. | - |
dc.contributor.author | Kim, J.J. | - |
dc.contributor.author | Yang, D.Y. | - |
dc.date.accessioned | 2021-09-06T09:58:05Z | - |
dc.date.available | 2021-09-06T09:58:05Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105967 | - |
dc.description.abstract | Purpose: The aim of the present study was to evaluate the effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia. Materials and Methods: A total of 138 male LUTS patients aged more than 50 years with an International Prostate Symptom Score (IPSS) ≥8 were enrolled in this open-la-bel, multicenter, prospective, noncomparative observational study. Clinical assess-ments included IPSS, quality of life (QoL) index, International Index of Erectile Function (IIEF), Danish Prostate Symptom Score (DAN-PSS), and an early morning erection questionnaire. The data were recorded at baseline and at 1 and 3 months after treatment with tamsulosin 0.2 mg/d. Adverse events were analyzed in all patients. Results: During the study period of 3 months, the IPSS and QoL index significantly improved from baseline by -11.40±9.40 and -1.11±1.36, respectively (p<0.001). However, there were no clinically relevant changes in total IIEF score (mean difference, 1.63±15.50; p=0.406) or the 5 subdomains (p>0.05). Furthermore, DAN-PSS weighted scores (A×B) showed no clinically relevant changes (mean difference on Q1, Q2, and Q3: -0.45±2.94, 0.27±2.50, and -1.27±2.27, p>0.05). In addition, there were no clin-ically significant changes in responses on the early morning erection questionnaire. Conclusions: Tamsulosin at the dose of 0.2 mg significantly improved the IPSS and the QoL index compared with baseline. However, tamsulosin did not exhibit any significant impact on sexual function or any negative impact on ejaculatory function. © The Korean Urological Association, 2013. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | prostate specific antigen | - |
dc.subject | tamsulosin | - |
dc.subject | adult | - |
dc.subject | article | - |
dc.subject | dizziness | - |
dc.subject | dyspepsia | - |
dc.subject | ejaculation disorder | - |
dc.subject | erectile dysfunction | - |
dc.subject | follow up | - |
dc.subject | headache | - |
dc.subject | human | - |
dc.subject | International Index of Erectile Function | - |
dc.subject | International Prostate Symptom Score | - |
dc.subject | low drug dose | - |
dc.subject | lower urinary tract symptom | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | observational study | - |
dc.subject | open study | - |
dc.subject | prospective study | - |
dc.subject | prostate hypertrophy | - |
dc.subject | quality of life index | - |
dc.subject | sexual function | - |
dc.subject | sperm | - |
dc.title | Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, J.J. | - |
dc.identifier.doi | 10.4111/kju.2013.54.10.697 | - |
dc.identifier.scopusid | 2-s2.0-84886283152 | - |
dc.identifier.bibliographicCitation | Korean Journal of Urology, v.54, no.10, pp.697 - 702 | - |
dc.relation.isPartOf | Korean Journal of Urology | - |
dc.citation.title | Korean Journal of Urology | - |
dc.citation.volume | 54 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 697 | - |
dc.citation.endPage | 702 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001812689 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | prostate specific antigen | - |
dc.subject.keywordPlus | tamsulosin | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | dizziness | - |
dc.subject.keywordPlus | dyspepsia | - |
dc.subject.keywordPlus | ejaculation disorder | - |
dc.subject.keywordPlus | erectile dysfunction | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | headache | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | International Index of Erectile Function | - |
dc.subject.keywordPlus | International Prostate Symptom Score | - |
dc.subject.keywordPlus | low drug dose | - |
dc.subject.keywordPlus | lower urinary tract symptom | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | observational study | - |
dc.subject.keywordPlus | open study | - |
dc.subject.keywordPlus | prospective study | - |
dc.subject.keywordPlus | prostate hypertrophy | - |
dc.subject.keywordPlus | quality of life index | - |
dc.subject.keywordPlus | sexual function | - |
dc.subject.keywordPlus | sperm | - |
dc.subject.keywordAuthor | Ejaculation | - |
dc.subject.keywordAuthor | Erectile dysfunction | - |
dc.subject.keywordAuthor | Lower urinary tract symptoms | - |
dc.subject.keywordAuthor | Prostatic hyperplasia | - |
dc.subject.keywordAuthor | Tamsulosin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.